Egypt pioneering biosimilar adoption in Middle East, Africa: Act4Biosimilars
Egypt is emerging as a leader in the adoption of biosimilar medicines…
EIPICO targets 2023 start of Biosimilar Project with EGP 400-600m revenues in 1st year
Local market size for oncology and hormone-based products is estimated at EGP1.5bn,…
